| Dr Thomas E Lawrie, MD | |
|
7910 Frost Street, Suite 245, San Diego, CA 92123 | |
| (858) 650-5037 | |
| (858) 650-5039 |
| Full Name | Dr Thomas E Lawrie |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 27 Years |
| Location | 7910 Frost Street, San Diego, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124020755 | NPI | - | NPPES |
| 00A747210 | Medicaid | CA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sharp Memorial Hospital | San diego, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chest Medicine And Critical Care Medical Group Inc | 6103898259 | 26 |
| Emergency And Acute Care Medical Corporation | 9537108279 | 382 |
News Archive
Advaxis Inc. completed its filing of a new investigational new drug ("IND") application with the U.S. Food and Drug Administration ("FDA"). This filing follows the successful completion of a Phase I study overseas.
Cancer Research UK-funded scientists have discovered that linking a molecule which initiates antibody production,to a 'saboteur' molecule, triggers the immune system to selectively destroy faulty cells. These findings published in Blood, could potentially be used to selectively destroy tumour cells while ignoring healthy cells.
Designers of anti-cancer drugs are aiming their arrows at mysterious chunks of the genetic material DNA that may play a key role in preventing the growth and spread of cancer cells, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
New research led by an academic at the University of East Anglia suggests that insights from behavioural science can help inform the design of road signs to bring about changes in driver behaviour.
Scientists from the London School of Hygiene say a quick "air kiss" on the cheek is a relatively-germ free affair when compared to a hand-shake.
› Verified 6 days ago
| Entity Name | Chest Medicine And Critical Care Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841292521 PECOS PAC ID: 6103898259 Enrollment ID: O20040809001379 |
News Archive
Advaxis Inc. completed its filing of a new investigational new drug ("IND") application with the U.S. Food and Drug Administration ("FDA"). This filing follows the successful completion of a Phase I study overseas.
Cancer Research UK-funded scientists have discovered that linking a molecule which initiates antibody production,to a 'saboteur' molecule, triggers the immune system to selectively destroy faulty cells. These findings published in Blood, could potentially be used to selectively destroy tumour cells while ignoring healthy cells.
Designers of anti-cancer drugs are aiming their arrows at mysterious chunks of the genetic material DNA that may play a key role in preventing the growth and spread of cancer cells, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
New research led by an academic at the University of East Anglia suggests that insights from behavioural science can help inform the design of road signs to bring about changes in driver behaviour.
Scientists from the London School of Hygiene say a quick "air kiss" on the cheek is a relatively-germ free affair when compared to a hand-shake.
› Verified 6 days ago
| Entity Name | Emergency And Acute Care Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437103942 PECOS PAC ID: 9537108279 Enrollment ID: O20050502000734 |
News Archive
Advaxis Inc. completed its filing of a new investigational new drug ("IND") application with the U.S. Food and Drug Administration ("FDA"). This filing follows the successful completion of a Phase I study overseas.
Cancer Research UK-funded scientists have discovered that linking a molecule which initiates antibody production,to a 'saboteur' molecule, triggers the immune system to selectively destroy faulty cells. These findings published in Blood, could potentially be used to selectively destroy tumour cells while ignoring healthy cells.
Designers of anti-cancer drugs are aiming their arrows at mysterious chunks of the genetic material DNA that may play a key role in preventing the growth and spread of cancer cells, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
New research led by an academic at the University of East Anglia suggests that insights from behavioural science can help inform the design of road signs to bring about changes in driver behaviour.
Scientists from the London School of Hygiene say a quick "air kiss" on the cheek is a relatively-germ free affair when compared to a hand-shake.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas E Lawrie, MD 7910 Frost Street, Suite 245, San Diego, CA 92123 Ph: (858) 650-5037 | Dr Thomas E Lawrie, MD 7910 Frost Street, Suite 245, San Diego, CA 92123 Ph: (858) 650-5037 |
News Archive
Advaxis Inc. completed its filing of a new investigational new drug ("IND") application with the U.S. Food and Drug Administration ("FDA"). This filing follows the successful completion of a Phase I study overseas.
Cancer Research UK-funded scientists have discovered that linking a molecule which initiates antibody production,to a 'saboteur' molecule, triggers the immune system to selectively destroy faulty cells. These findings published in Blood, could potentially be used to selectively destroy tumour cells while ignoring healthy cells.
Designers of anti-cancer drugs are aiming their arrows at mysterious chunks of the genetic material DNA that may play a key role in preventing the growth and spread of cancer cells, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
New research led by an academic at the University of East Anglia suggests that insights from behavioural science can help inform the design of road signs to bring about changes in driver behaviour.
Scientists from the London School of Hygiene say a quick "air kiss" on the cheek is a relatively-germ free affair when compared to a hand-shake.
› Verified 6 days ago
Dr. Ramin Motarjemi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 858-249-2500 Fax: 858-657-8069 | |
Dr. Shweta Warner, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-221-6258 Fax: 619-221-6012 | |
Dr. Matthew James Roosevelt, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, Department Of Hospital Medicine, San Diego, CA 92120 Phone: 619-952-5091 | |
Dr. Daniel Joseph Desantis, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: Naval Medical Ctr, 34800 Bob Wilson Dr., San Diego, CA 92134 Phone: 619-532-7935 | |
Kris Kumar, Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 Fax: 888-539-8781 | |
Jedidiah Daniel Bell, Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 619-471-0434 | |
Dr. Umber Dube, MD PHD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 8899 University Center Lane, Suite 350 Mc 0975, San Diego, CA 92122 Phone: 858-657-1675 |